CESTAT Chennai: 'Helmisol' Classified as Medicaments, Penalties Reduced The Appellate Tribunal CESTAT, CHENNAI partially allowed the appeal, upholding the classification of 'Helmisol' under Tariff Heading 30.03 as medicaments. ...
Cases where this provision is explicitly mentioned in the judgment/order text; may not be exhaustive. To view the complete list of cases mentioning this section, Click here.
Provisions expressly mentioned in the judgment/order text.
CESTAT Chennai: "Helmisol" Classified as Medicaments, Penalties Reduced
The Appellate Tribunal CESTAT, CHENNAI partially allowed the appeal, upholding the classification of "Helmisol" under Tariff Heading 30.03 as medicaments. The penalty under Rule 25 of the Central Excise Rules, 2002 was reduced to Rs.6,500, and the penalty under Rule 13 of the CENVAT Credit Rules, 2002 was upheld at Rs.5,000.
Issues involved: Correct classification of "Helmisol" under Tariff Heading 23.02 or 30.03, penalty imposed under Rule 25 of Central Excise Rules, 2002, penalty imposed under Rule 13 of CENVAT Credit Rules, 2002.
Correct Classification Issue Analysis: The dispute in the appeal pertains to the classification of "Helmisol" as either animal feed under Tariff Heading 23.02 or as medicaments under Tariff Heading 30.03. The Tribunal found no merit in the appellant's claim, noting the lack of evidence that the product is commonly known as an animal feed supplement in the market. Additionally, the appellant had initially classified the product under Tariff Heading 30.03 and obtained a drug license for it before changing the classification to Tariff Heading 23.02 without altering the product composition. Consequently, the Tribunal upheld the classification under Tariff Heading 30.03.
Penalty under Rule 25 of Central Excise Rules, 2002 Analysis: Regarding the penalty of Rs.10,000 imposed under Rule 25 of the Central Excise Rules, 2002, the Tribunal deemed it justified due to the appellant's actions of changing the product classification, adding "poultry feed supplement" on the label, and removing the drug license number to potentially evade the appropriate duty under Tariff Heading 30.03. However, considering the duty demand confirmed at Rs.65,567, the Tribunal reduced the penalty to Rs.6,500.
Penalty under Rule 13 of CENVAT Credit Rules, 2002 Analysis: The Tribunal upheld the penalty of Rs.5,000 imposed under Rule 13 of the CENVAT Credit Rules, 2002. This decision was based on the appellant's reversal of 8% of the amount of the price, applicable as they manufactured both dutiable and exempted products, only after receiving a show cause notice. The Tribunal found this reversal to be post-facto and upheld the penalty.
In conclusion, the appeal was partially allowed by the Appellate Tribunal CESTAT, CHENNAI, with the classification of "Helmisol" under Tariff Heading 30.03 upheld. The penalty under Rule 25 of the Central Excise Rules, 2002 was reduced to Rs.6,500, and the penalty under Rule 13 of the CENVAT Credit Rules, 2002 was upheld at Rs.5,000.
Full Summary is available for active users!
Note: It is a system-generated summary and is for quick reference only.